HIV persistence: chemokines and their signalling pathways.

Area of Science:

• Immunology
• Virology
• Molecular Biology

Background:

• Latently infected resting CD4+ T cells represent a significant obstacle to curing HIV.
• Chemokines binding to CCR7, CXCR3, and CCR6 receptors are implicated in HIV nuclear localization and integration.
• These latently infected cells are concentrated in chemokine-rich lymphoid tissues, suggesting a mechanism for in vivo generation.

Purpose of the Study:

• To review the role of chemokines in HIV persistence.
• To outline the key signaling pathways involved in chemokine-mediated HIV latency.
• To explore potential therapeutic strategies targeting these pathways for HIV eradication.

Main Methods:

• Literature review of studies on chemokines, HIV latency, and CD4+ T cell signaling.
• Analysis of signaling pathways mediating HIV nuclear import and integration.
• Discussion of potential therapeutic targets for eliminating latently infected cells.

Main Results:

• Chemokines binding to CCR7, CXCR3, and CCR6 receptors facilitate HIV nuclear localization and integration in resting CD4+ T cells.
• This process contributes to the establishment and maintenance of HIV latency.
• Lymphoid tissue microenvironment, rich in chemokines, likely promotes the generation of latently infected cells.

Conclusions:

• Chemokines play a critical role in establishing and maintaining HIV latency.
• Targeting chemokine signaling pathways offers a promising avenue for developing novel HIV cure strategies.
• Further research into these pathways is essential for reducing or eliminating the reservoir of latently infected cells.